The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACELRX PHARMACEUTICALS INC | COM | 00444T100 | 176 | 57,747 | SH | SOLE | 57,747 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 733 | 106,104 | SH | SOLE | 106,104 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 3,247 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 5,164 | 33,021 | SH | SOLE | 33,021 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 5,096 | 86,864 | SH | SOLE | 86,864 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 3,893 | 48,448 | SH | SOLE | 48,448 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 778 | 5,626 | SH | SOLE | 5,626 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | COM | 04269X105 | 1,140 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| ARROWHEAD RESH CORP | COM NEW | 042797209 | 295 | 51,133 | SH | SOLE | 51,133 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 143 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,328 | 136,000 | SH | SOLE | 136,000 | 0 | 0 | ||
| AXOVANT SCIENCES LTD | COM | G0750W104 | 397 | 30,722 | SH | SOLE | 30,722 | 0 | 0 | ||
| BIO TECHNE CORP | COM | 09073M104 | 4,346 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 5,097 | 17,467 | SH | SOLE | 17,467 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 4,425 | 42,012 | SH | SOLE | 42,012 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 2,131 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | ||
| NOVAVAX INC | COM | 670002104 | 707 | 100,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| CELGENE CORP | COM | 151020104 | 5,099 | 47,137 | SH | SOLE | 47,137 | 0 | 0 | ||
| CEPHEID | COM | 15670R107 | 4,068 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 541 | 14,152 | SH | SOLE | 14,152 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 5,386 | 58,567 | SH | SOLE | 58,567 | 0 | 0 | ||
| CURIS INC | COM | 231269101 | 756 | 374,500 | SH | SOLE | 374,500 | 0 | 0 | ||
| DIREXION SHS ETF TR | COM | 25490K752 | 241 | 14,850 | SH | SOLE | 14,850 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 593 | 46,079 | SH | SOLE | 46,079 | 0 | 0 | ||
| FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 926 | 56,788 | SH | SOLE | 56,788 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 122 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 424 | 4,323 | SH | SOLE | 4,323 | 0 | 0 | ||
| HOLOGIC INC | COM | 436440101 | 1,878 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 4,982 | 28,334 | SH | SOLE | 28,334 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 5,230 | 47,400 | SH | SOLE | 47,400 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 383 | 45,300 | SH | SOLE | 45,300 | 0 | 0 | ||
| ISHARES TR | NASDQ BIOTEC ETF | 464287556 | 6,067 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ISIS PHARMACEUTICALS INC | COM | 464330109 | 4,099 | 101,401 | SH | SOLE | 101,401 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 155 | 14,750 | SH | SOLE | 14,750 | 0 | 0 | ||
| MEDIVATION INC | COM | 58501N101 | 5,031 | 118,372 | SH | SOLE | 118,372 | 0 | 0 | ||
| MERCK & CO INC NEW | COM | 58933Y105 | 2,025 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
| MERRIMACK PHARMACEUTICALS IN | COM | 590328100 | 528 | 62,009 | SH | SOLE | 62,009 | 0 | 0 | ||
| METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 4,328 | 15,200 | SH | SOLE | 15,200 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 1,635 | 102,200 | SH | SOLE | 102,200 | 0 | 0 | ||
| NATIONAL HOLDINGS CORP | COM NEW | 636375206 | 246 | 89,530 | SH | SOLE | 89,530 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 4,869 | 444,258 | SH | SOLE | 444,258 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 290 | 7,150 | SH | SOLE | 7,150 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | COM | 695127100 | 863 | 21,000 | SH | SOLE | 21,000 | 0 | 0 | ||
| PROSHARES TR | PSHS ULT NASB | 74347R214 | 1,906 | 32,717 | SH | SOLE | 32,717 | 0 | 0 | ||
| NOVAVAX INC | COM | 670002104 | 707 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
| SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 53,691 | 862,500 | SH | Put | SOLE | 862,500 | 0 | 0 | |
| QIAGEN NV | REG SHS | N72482107 | 4,128 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 4,943 | 10,627 | SH | SOLE | 10,627 | 0 | 0 | ||
| SEATTLE GENETICS INC | COM | 812578102 | 4,803 | 124,558 | SH | SOLE | 124,558 | 0 | 0 | ||
| STEMLINE THERAPEUTICS INC | COM | 85858C107 | 662 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 731 | 5,571 | SH | SOLE | 5,571 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 900 | 332,157 | SH | SOLE | 332,157 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 4,257 | 40,876 | SH | SOLE | 40,876 | 0 | 0 | ||
| REPROS THERAPEUTICS INC | COM NEW | 76028H209 | 494 | 98,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| XENOPORT INC | COM | 98411C100 | 139 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| ZOGENIX INC | COM NEW | 98978L204 | 887 | 65,700 | SH | SOLE | 65,700 | 0 | 0 | ||